The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain

We aimed to describe sociodemographic, comorbidities, co-medication and risk of thromboembolic events and bleeding in patients with NVAF initiating oral anticoagulants (OAC) for stroke prevention, and to estimate adherence and persistence to OAC. Primary Health Care (PHC) in the Catalan Health Insti...

Descripción completa

Detalles Bibliográficos
Autores: Giner-Soriano, Maria|||0000-0003-3750-9233, Cortés, Jordi|||0000-0002-3764-0795, Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402, Prat Vallverdú, Oriol, Quijada-Manuitt, María Ángeles|||0000-0002-9624-0177, Morros, Rosa|||0000-0001-6752-8748
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:232716
Acceso en línea:https://ddd.uab.cat/record/232716
https://dx.doi.org/urn:doi:10.1016/j.aprim.2020.05.016
Access Level:acceso abierto
Palabra clave:Atrial fibrillation
Oral anticoagulants
Adherence
Persistence
Electronic health records
Fibrilación auricular
Tratamiento anticoagulante oral
Adherencia
Persistencia
Registros electrónicos de salud
id ES_0ef1844edeb934e2caa8e69abe5afbc5
oai_identifier_str oai:ddd.uab.cat:232716
network_acronym_str ES
network_name_str España
repository_id_str
spelling The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spaina real-world data cohort studyGiner-Soriano, Maria|||0000-0003-3750-9233Cortés, Jordi|||0000-0002-3764-0795Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402Prat Vallverdú, OriolQuijada-Manuitt, María Ángeles|||0000-0002-9624-0177Morros, Rosa|||0000-0001-6752-8748Atrial fibrillationOral anticoagulantsAdherencePersistenceElectronic health recordsFibrilación auricularTratamiento anticoagulante oralAdherenciaPersistenciaRegistros electrónicos de saludWe aimed to describe sociodemographic, comorbidities, co-medication and risk of thromboembolic events and bleeding in patients with NVAF initiating oral anticoagulants (OAC) for stroke prevention, and to estimate adherence and persistence to OAC. Primary Health Care (PHC) in the Catalan Health Institute (ICS), Catalunya, Spain. All NVAF adult patients initiating OAC for stroke prevention in August 2013-December 2015. Population-based cohort study. Persistence was measured in patients initiating OAC in August 2013-December 2014. Data source: SIDIAP, which captures electronic health records from PHC in the (ICS), covering approximately 5.8 million people. 51,690 NVAF patients initiated OAC; 47,197 (91.3%) were naive to OAC and 32,404 (62.7%) initiated acenocoumarol. Mean age was 72.8 years (SD 12.3) and 49.4% were women. Platelet-aggregation inhibitors were taken by 9105 (17.6%) of the patients. Persistence and adherence were estimated up to the end of follow-up. For 22,075 patients, persistence was higher among the non-naive patients [ n = 258 (61.7%)] than among the naive [ n = 11,502 (53.1%)]. Adherence was estimated for patients initiating DOAC and it was similar in naive and non-naive patients. Among the naive to DOAC treatment, those starting rivaroxaban showed a highest proportion [(n = 360 (80.1%)] of good adherence at implementation (MPR.Universitat Autònoma de Barcelona 22020-01-0120202020-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/232716https://dx.doi.org/urn:doi:10.1016/j.aprim.2020.05.016reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:2327162026-06-06T12:50:31Z
dc.title.none.fl_str_mv The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
a real-world data cohort study
title The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
spellingShingle The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
Giner-Soriano, Maria|||0000-0003-3750-9233
Atrial fibrillation
Oral anticoagulants
Adherence
Persistence
Electronic health records
Fibrilación auricular
Tratamiento anticoagulante oral
Adherencia
Persistencia
Registros electrónicos de salud
title_short The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
title_full The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
title_fullStr The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
title_full_unstemmed The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
title_sort The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain
dc.creator.none.fl_str_mv Giner-Soriano, Maria|||0000-0003-3750-9233
Cortés, Jordi|||0000-0002-3764-0795
Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402
Prat Vallverdú, Oriol
Quijada-Manuitt, María Ángeles|||0000-0002-9624-0177
Morros, Rosa|||0000-0001-6752-8748
author Giner-Soriano, Maria|||0000-0003-3750-9233
author_facet Giner-Soriano, Maria|||0000-0003-3750-9233
Cortés, Jordi|||0000-0002-3764-0795
Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402
Prat Vallverdú, Oriol
Quijada-Manuitt, María Ángeles|||0000-0002-9624-0177
Morros, Rosa|||0000-0001-6752-8748
author_role author
author2 Cortés, Jordi|||0000-0002-3764-0795
Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402
Prat Vallverdú, Oriol
Quijada-Manuitt, María Ángeles|||0000-0002-9624-0177
Morros, Rosa|||0000-0001-6752-8748
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universitat Autònoma de Barcelona
dc.subject.none.fl_str_mv Atrial fibrillation
Oral anticoagulants
Adherence
Persistence
Electronic health records
Fibrilación auricular
Tratamiento anticoagulante oral
Adherencia
Persistencia
Registros electrónicos de salud
topic Atrial fibrillation
Oral anticoagulants
Adherence
Persistence
Electronic health records
Fibrilación auricular
Tratamiento anticoagulante oral
Adherencia
Persistencia
Registros electrónicos de salud
description We aimed to describe sociodemographic, comorbidities, co-medication and risk of thromboembolic events and bleeding in patients with NVAF initiating oral anticoagulants (OAC) for stroke prevention, and to estimate adherence and persistence to OAC. Primary Health Care (PHC) in the Catalan Health Institute (ICS), Catalunya, Spain. All NVAF adult patients initiating OAC for stroke prevention in August 2013-December 2015. Population-based cohort study. Persistence was measured in patients initiating OAC in August 2013-December 2014. Data source: SIDIAP, which captures electronic health records from PHC in the (ICS), covering approximately 5.8 million people. 51,690 NVAF patients initiated OAC; 47,197 (91.3%) were naive to OAC and 32,404 (62.7%) initiated acenocoumarol. Mean age was 72.8 years (SD 12.3) and 49.4% were women. Platelet-aggregation inhibitors were taken by 9105 (17.6%) of the patients. Persistence and adherence were estimated up to the end of follow-up. For 22,075 patients, persistence was higher among the non-naive patients [ n = 258 (61.7%)] than among the naive [ n = 11,502 (53.1%)]. Adherence was estimated for patients initiating DOAC and it was similar in naive and non-naive patients. Among the naive to DOAC treatment, those starting rivaroxaban showed a highest proportion [(n = 360 (80.1%)] of good adherence at implementation (MPR.
publishDate 2020
dc.date.none.fl_str_mv 2
2020-01-01
2020
2020-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/232716
https://dx.doi.org/urn:doi:10.1016/j.aprim.2020.05.016
url https://ddd.uab.cat/record/232716
https://dx.doi.org/urn:doi:10.1016/j.aprim.2020.05.016
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403426107949056
score 15.300719